Review of the use of Janus kinase inhibitors in the treatment of scarring alopecia

Ambika Nohria; Deesha Desai; Jerry Shapiro; Lindsey Bordone; Kristen Lo Sicco

doi:10.1111/ijd.17153

Review of the use of Janus kinase inhibitors in the treatment of scarring alopecia

Int J Dermatol. 2024 Jun;63(6):e105-e110. doi: 10.1111/ijd.17153. Epub 2024 Apr 3.

Authors

Ambika Nohria^#¹, Deesha Desai^#^{1

2}, Jerry Shapiro¹, Lindsey Bordone³, Kristen Lo Sicco¹

Affiliations

¹ The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
² University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
³ Department of Dermatology, Columbia University Medical Center, New York, NY, USA.

^# Contributed equally.

PMID: 38571280
DOI: 10.1111/ijd.17153

No abstract available

Keywords: JAK inhibitor; Janus kinase inhibitor; central centrifugal cicatricial alopecia; cicatricial alopecia; dissecting cellulitis of the scalp; folliculitis decalvans; frontal fibrosing alopecia; lichen planopilaris; scarring alopecia.

Publication types

Review
Letter

MeSH terms

Alopecia* / drug therapy
Azetidines
Cicatrix* / drug therapy
Cicatrix* / etiology
Heterocyclic Compounds, 3-Ring
Humans
Janus Kinase Inhibitors* / therapeutic use
Nitriles / therapeutic use
Piperidines
Purines
Pyrazoles / therapeutic use
Pyrimidines / therapeutic use
Sulfonamides / therapeutic use
Treatment Outcome

Substances

Janus Kinase Inhibitors
tofacitinib
ruxolitinib
Pyrazoles
Pyrimidines
Nitriles
baricitinib
Sulfonamides
upadacitinib
Azetidines
Heterocyclic Compounds, 3-Ring
Piperidines
Purines